Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023
Geneva, Switzerland, November 23, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that that it will issue its Third Quarter …